VanEck Pharmaceutical ETF (PPH)

Profile

VanEck Pharmaceutical ETF is an exchange-traded fund that provides focused exposure to the pharmaceutical industry through a portfolio of U.S.-listed companies involved in drug discovery, development, production, marketing, and sales. The fund is designed to track the MVIS US Listed Pharmaceutical 25 Index, giving investors access to a concentrated group of large and established pharmaceutical names across human health and related healthcare segments. Its holdings typically include companies engaged in prescription medicines, specialty therapies, and branded pharmaceutical products, along with businesses that support global drug distribution and commercialization. VanEck Pharmaceutical ETF is used by market participants seeking a sector-specific instrument that reflects the performance of the pharmaceutical market rather than the broader healthcare space. The fund combines a passive index-based structure with diversified exposure across leading pharmaceutical firms, making it a common reference point for tracking trends in drugmakers and related healthcare innovation.